Description
An orally bioavailable inhibitor ASK1 inhibitor (IC50 = 3.2 nM); a formulation containing selonsertib showed antifibrotic activity in a Phase II clinical trial; other clinical trials are ongoing
Formal name: 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-[6-[4-(1-methylethyl)-4H-1,2,4-triazol-3-yl]-2-pyridinyl]-benzamide
Synonyms: GS-4977|GS-4997
Molecular weight: 445.5
CAS: 1448428-04-3
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Serine/Threonine Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Endocrinology & Metabolism|Metabolic Diseases|NAFLD & NASH